Compliance Action

PO Wealth Sharing Group claims 200,000 users and a global footprint. But beneath the surface of this fintech success story lies a troubling pattern.

An $85,000 fine and a revoked licence for a mortgage broker is just the start. We explore how Ontario's regulator is tightening its grip on the industry.

A New York non-profit's monthly alert reveals the street-level tactics of a massive illicit industry. But the real story is the multi-front war being waged by regulators and citizens against a fraud enterprise that costs taxpayers billions.

New UK safety rules for engineered stone reveal a deadly dust crisis. As regulators crack down, the industry faces a choice: control the risk or change the material.

A recall of 'vegan' puffs containing milk exposes critical supply chain flaws and a crisis of trust, signaling major challenges for the booming plant-based industry.

Beyond new features like hotel cancellation flexibility, HTS's summer update reveals a firm identity: a B2B tech engine powering global travel's bottom line.

Hub Group touts tech-driven logistics but faces a crisis over deep accounting flaws, testing investor trust and proving that back-office integrity is paramount.

uCloudlink's stock is below $1, triggering a Nasdaq delisting threat. Is this a market blip or a fatal sign that its 'data sharing' dream is fading?

Republic Technologies is trading again after a costly regulatory halt. While its shares bounce, a deeper dive into its finances reveals the hidden risks.

A Texas tech firm just earned a major security certification for its AI. It's more than a press release—it's a blueprint for building trust in an industry on edge.

As the AI boom threatens to overwhelm the Texas grid, a new state audit forces a reckoning. Can developers prove they are assets, not just burdens?

A key partner's FDA stumble could have derailed a vital new SMA drug. Instead, Scholar Rock's foresight kept the approval on track, showing why it pays to plan for the worst.

The hormone optimization leader's stock tumbles after Q2 results show a net loss and declining revenue, revealing the prolonged impact of its January recall.

A recall of a vital pet arthritis drug due to glass fibers reveals a history of quality control failures, forcing a difficult reckoning for pet owners and vets.

Amidst banking boycotts, Credova built a fintech empire for firearms. We explore how its 'uncancellable' ecosystem is reshaping the gun rights debate.

With $921 million funded in H1 2026, BridgePeak Energy Capital is doing more than closing loans; it's laying the financial rails for America's converged energy and digital future.

A $5,500 fine for a recreational poacher reveals the fragile system behind B.C.'s fisheries, where data, conservation, and community hang in the balance.

A new study on umbilical cord allografts offers hope for chronic neck pain, but a closer look reveals the complex scientific and regulatory networks that will define its future.

The DOJ's agreement with Weill Cornell isn't just about one hospital's failure. It's a signal of intent, redrawing the lines of corporate liability in healthcare.

Nexo has pioneered a partner-led model for MiCAR compliance, splitting custody and brokerage. Is this the new standard for global crypto firms in the EU?